PART 6 • CHAPTER 19

Weight Loss Medications: Facts for Patients

Who Needs Weight Loss Medications?

Medications are indicated when lifestyle changes alone aren't sufficient and obesity is causing health problems.

Medical Criteria for Medications

  • BMI ≥27.5 with obesity-related diseases (diabetes, hypertension, PCOS, sleep apnea)
  • BMI ≥32.5 even without complications (Indian cut-offs)
  • After 3-6 months of lifestyle changes without adequate weight loss
  • Unable to lose or maintain weight with diet/exercise alone
Key Point: Medications are ADDITION to lifestyle changes, not replacement. They help overcome biological resistance but only work with concurrent diet and exercise efforts.

Approved Weight Loss Medications in India

1. Orlistat (Xenical, Alli)

How it works: Blocks 25-30% of dietary fat absorption

Effectiveness:

  • Average 3-5% total body weight loss over 1 year
  • Plus lifestyle changes: 5-10% loss possible

Pros:

  • Not absorbed systemically (works in gut)
  • Long safety record
  • Train you to eat less fat (negative reinforcement)

Cons/Side Effects:

  • Oily stools, flatulence, urgency (especially if eating high-fat meals)
  • May reduce absorption of fat-soluble vitamins (A, D, E, K)
  • Must take with meals
  • Side effects limit compliance

Dose: 120 mg three times daily with meals

2. Liraglutide (Saxenda) - GLP-1 Agonist

How it works: Mimics natural gut hormone GLP-1; reduces appetite, slows stomach emptying

Effectiveness:

  • Average 5-10% total body weight loss
  • Also improves blood sugar, cardiovascular markers

Pros:

  • Significant weight loss
  • Improves diabetes control dramatically
  • Cardiovascular benefits (reduces heart attack risk)
  • Once-daily injection

Cons/Side Effects:

  • Injection (not pill)—some dislike this
  • Nausea initially (usually subsides in 2-4 weeks)
  • Expensive (₹15,000-20,000/month)
  • Risk of pancreatitis (rare)

Dose: Start 0.6 mg daily, increase weekly to 3 mg

3. Semaglutide (Wegovy) - Newer GLP-1 Agonist

How it works: Similar to liraglutide, longer-acting

Effectiveness:

  • Average 10-15% total body weight loss
  • Currently most effective medication approved

Pros:

  • Weekly injection (vs daily for liraglutide)
  • Higher weight loss than other options
  • Cardiovascular and diabetes benefits

Cons/Side Effects:

  • Very expensive (₹20,000-30,000/month)
  • Limited availability in India currently
  • Similar side effects to liraglutide (nausea)

Dose: Start 0.25 mg weekly, titrate to 2.4 mg

4. Phentermine-Topiramate (Qsymia)

Availability in India: Not officially approved but sometimes used off-label

How it works: Combination reduces appetite, increases satiety

Effectiveness: 7-10% weight loss

Notable side effects: Dry mouth, constipation, heart palpitations, cannot use if pregnant

5. Metformin (Off-label use)

Primary use: Diabetes medication

For obesity:

  • Modest weight loss (2-3 kg)
  • Helpful with insulin resistance, PCOS
  • Very affordable
  • Often first medication tried in India for obese prediabetics/PCOS

Side effects: GI upset initially, vitamin B12 deficiency with long-term use

Safety and Effectiveness

What "Effective" Means

  • Medications help lose additional 3-10% beyond lifestyle alone
  • Not magic pills—still need diet and exercise
  • Individual variation: some lose significantly more, some less
  • Maintain weight loss only while taking medication

Safety Considerations

  • All approved medications tested in thousands of patients
  • Benefits outweigh risks for appropriate candidates
  • Require medical supervision
  • Regular monitoring for side effects
Never Use: Unapproved "herbal" weight loss supplements, drugs banned in India (sibutramine, rimonabant, etc.). These can cause serious harm including heart attacks, liver damage, psychiatric problems.

Common Myths About Weight Loss Medications

Myth #1: "Medications are a shortcut/easy way out"

Reality: Medications are tools to overcome biological resistance. Still require diet, exercise, behavioral changes. Not easier—just addresses the biological disadvantage.

Myth #2: "Weight loss drugs are dangerous"

Reality: Approved medications are tested extensively. For appropriate candidates, benefits (reducing diabetes, heart disease) far outweigh risks. Untreated obesity is more dangerous than approved medications.

Myth #3: "I'll become dependent/addicted"

Reality: Obesity medications aren't addictive. Needing long-term medication for chronic disease isn't "dependency"—it's appropriate treatment (like needing blood pressure medication long-term).

Myth #4: "Natural/herbal supplements are safer"

Reality: "Natural" doesn't mean safe. Many herbal supplements are unregulated, untested, and can contain harmful contaminants. Prescription medications are much more rigorously tested.

Myth #5: "Medications will solve everything"

Reality: Medications enhance lifestyle changes, don't replace them. Without continued diet/exercise, results are minimal.

Setting Realistic Expectations

What to Expect with Medications

  • Weight loss magnitude: 5-15% of starting weight over 6-12 months
  • Rate: 0.5-1 kg/week initially, slowing over time
  • Plateau: Weight loss plateaus after 6-12 months even on medication
  • Maintenance: Continue medication to maintain loss
  • Regain if stopped: Most regain weight after stopping (this is expected—obesity is chronic)

Success Criteria

  • ≥5% weight loss = clinically meaningful (improves health markers)
  • If <5% loss after 3 months at full dose → try different medication
  • Focus on health improvements, not just number on scale

Cost Considerations in India

Price Range (Approximate)

  • Orlistat: ₹2,000-4,000/month
  • Metformin: ₹200-500/month (off-label)
  • Liraglutide: ₹15,000-20,000/month
  • Semaglutide: ₹20,000-30,000/month

Cost-benefit analysis:

  • Compare to cost of treating diabetes, heart disease complications
  • Preventing diabetes saves ₹2,000-5,000/month on diabetes medications
  • Discuss generic options with doctor
  • Some medications available in tiered pricing

Key Takeaways

  • Medications indicated for BMI ≥27.5 with complications or ≥32.5 without
  • Orlistat (blocks fat), liraglutide and semaglutide (GLP-1 agonists) are main approved options
  • Medications add 3-10% weight loss beyond lifestyle alone—not magic pills
  • GLP-1 agonists (liraglutide, semaglutide) most effective: 10-15% weight loss
  • All medications require concurrent diet and exercise to work
  • Weight loss maintained only while taking medication—stopping leads to regain
  • Approved medications are safe for appropriate candidates; benefits outweigh risks
  • Avoid unapproved herbal supplements and banned drugs (dangerous)
  • ≥5% weight loss is clinically significant—improves health markers dramatically
  • Cost ranges ₹2,000-30,000/month; consider long-term health cost savings
← Previous: Chapter 18 Next: Chapter 20 →